13F filing recap · Q3 2005

What did Icahn Capital LP buy in Q3 2005?

Reported stock-position changes between this filing and the previous one.

Stock value

$2.18B

Positions

Estimated turnover

24.5%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

TKTXTranskaryotic Therapies Inc$13.38Mreported value+361.5K shares BKFGBkf Capital Group$10.05Mreported value+325.0K shares ANXAdventrx Pharmaceuticals$2.94Mreported value+864.9K shares

Increased positions

BBIBlockbuster, Inc$48.93Mreported value+3.4K shares+0.1%

Exited positions

MYLMylan N.v.$505.85Mprior reported value-26.29M shares-100.0%